ClinicalTrials.Veeva

Menu

Caffeine and the Autonomic Nervous System

L

LMU Klinikum

Status

Unknown

Conditions

Autonomic Nervous System Imbalance

Treatments

Dietary Supplement: caffeine

Study type

Interventional

Funder types

Other

Identifiers

NCT04886869
CaffeineLMU

Details and patient eligibility

About

Caffeine consumption has been linked to dysfunction of the autonomic nervous system. In this study the investigators analyze the effects of caffeine containing drinks (including energy drinks and coffee) on ECG based parameters of the autonomic nervous system.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy individuals
  • > 18 years

Exclusion criteria

  • known cardiovascular disease
  • other diseases which may influence the autonomic nervous system
  • medication which may influence the autonomic nervous system
  • prior caffeine consumption (<24 hours)

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

20 participants in 3 patient groups, including a placebo group

Coffee
Experimental group
Description:
Oral consumption of 3 cups of coffee containing 240 mg caffeine
Treatment:
Dietary Supplement: caffeine
Energy drink
Experimental group
Description:
Oral consumption of 750 mL of a commercial energy drink containing 240 mg caffeine
Treatment:
Dietary Supplement: caffeine
Placebo
Placebo Comparator group
Description:
Oral consumption of 750 mL water
Treatment:
Dietary Supplement: caffeine

Trial contacts and locations

1

Loading...

Central trial contact

Stefan Brunner, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems